Aru A , Munl-Nielsen L , Federspiel BH , 1997. The soil fungus Chaetomium in the human paranasal sinus. Eur Arch Otorhinolaryngol 254: 350–352.
Anandi V et al.1989. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol 27: 2226–2229.
Clinical Laboratory Standards Institute (CLSI) , 2017. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 3rd ed. CLSI Standard M38.
Yu J , Yang S , Zhao Y , Li R , 2006. A case of subcutaneous phaeohyphomycosis caused by Chaetomium globosum and the sequences analysis of C. globosum. Med Mycol 44: 541–545.
Al-Aidaroos A , Bin-Hussain I , El Solh H , Kofide A , Thawadi S , Belgaumi A , Al Ahmari A , 2007. Invasive chaetomium infection in two immunocompromised pediatric patients. Pediatr Infect Dis J 26: 456–458.
Tabbara KF , Wedin K , Haddab SA , 2010. Chaetomium retinitis. Retin Cases Brief Rep 4: 8–10.
Tap RM , Sabaratnam P , Ahmad NA , Abd Razak MF , Hashim R , Ahmad N , 2015. Chaetomium globosum cutaneous fungal infection confirmed by molecular identification: a case report from Malaysia. Mycopathologia 180: 137–141.
Abbott SP , Sigler L , McAleer R , McGough DA , Rinaldi MG , Mizell G , 1995. Fatal cerebral mycosis caused by the ascomycete Chaetomium strumarium. J Clin Microbiol 33: 2692–2698.
Huppert M , Oliver DJ , Sun SH , 1978. Combined methenamine-silver nitrate and hematoxylin and eosin stain from fungi in tissues. J Clin Microbiol 8: 598–603.
Barron MA , Sutton DA , Veve R , Guarro J , Rinaldi M , Thompson E , Cagnoni PJ , Moultney K , Madinger NE , 2003. Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol 41: 5302–5307.
Arenas-Ruiz JA , Martínez-Maldonado H , González-Carranza V , Torres-García S , Chico-Ponce F , 2018. Endoscopic ventriculo-cisterno-ventricular approach in the treatment of bilateral trapped temporal horn related to fungal infection in a child: case report and review of the literature. Childs Nerv Syst 34: 1593–1597.
Guarner J , Brandt ME , 2011. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24: 247–280.
Ben-Ami R , Lewis RE , Raad II , Kontoyiannis DP , 2009. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 48: 1033–1041.
Chowdhary A et al.2014. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 20: 47–75.
Serena C , Ortoneda M , Capilla J , Pastor FJ , Sutton DA , Rinaldi MG , Guarro J , 2003. In vitro activities of new antifungal agents 238 against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother 47: 3161–3164.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 2256 | 589 | 18 |
Full Text Views | 80 | 57 | 10 |
PDF Downloads | 78 | 52 | 12 |
Chaetomium sp. is a mold, member of the phylum Ascomycota. Clinical disease in humans is rare, particularly in children, for which only five cases have been reported. We report a 7-months-old female patient with a diagnosis of visceral heterotaxy syndrome who was admitted to a private center in Mexico. After two episodes of focal myoclonic seizure, a brain magnetic resonance imaging (MRI) revealed a right porencephalic cyst and a right frontal abscess with ventriculitis. Seventy-two hours after temporal abscesses drainage procedure, the culture showed a rapidly growing pale white fungal colony. Sequencing of internal transcribed spacer (ITS) and D1/D2 led to the identification of Chaetomium strumarium. Although Chaetomium sp. is a rare fungal infection in humans, clinicians should consider it as a plausible etiologic agent that can form brain abscess.
Disclosure: Written informed consent was obtained from the patient’s parents for publication of the case details and accompanying images.
Authors’ addresses: Bárbara Cárdenas Del Castillo, Department of Pediatrics/Neonatal Intensive Care Unit, Hospital Universitario “Dr. José Eleuterio González,” Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: bgcardenas8@gmail.com. José Iván Castillo Bejarano, Department of Pediatrics/Infectious Diseases Service, Hospital Universitario “Dr. José Eleuterio González,” Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: jicastillobejarano@gmail.com. Oscar DeLaGarza-Pineda, Department of Neurology, Hospital Universitario “Dr. José Eleuterio González,” Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: odelagarza@neuropediatria.mx. José Ascención Arenas Ruiz, Department of Neurosurgery, Hospital Universitario “Dr. José Eleuterio González,” Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: joasarenas@gmail.com. Hiram Villanueva Lozano, Department of Microbiology, Facultad de Medicina, Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: dr.villanueval@hotmail.com. Rogelio de J. Treviño-Rangel, Department of Microbiology; Facultad de Medicina, Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: roghe24@gmail.com. Gloria González M., Department of Microbiology; Facultad de Medicina, Francisco I. Madero Avenue, Mitras Centro, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico, E-mail: gmglez@yahoo.com.mx. Joyce Marie García Martínez, Hospital Epidemiology Surveillance Unit; Christus Muguerza Hospital Alta Especialidad, Hidalgo Avenue, Obispado, Universidad de Monterrey, Monterrey, Mexico, E-mail: joyce.garcia@udem.edu.